These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Wang D; Bhat R; Sobel RA; Huang W; Wang LX; Olsson T; Steinman L Drug Dev Res; 2014 May; 75(3):172-88. PubMed ID: 24648292 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis. Serres S; Bristow C; de Pablos RM; Merkler D; Soto MS; Sibson NR; Anthony DC J Cereb Blood Flow Metab; 2013 May; 33(5):744-53. PubMed ID: 23423190 [TBL] [Abstract][Full Text] [Related]
5. The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes. Inoue M; Shinohara ML Immunology; 2013 May; 139(1):11-8. PubMed ID: 23360426 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821 [TBL] [Abstract][Full Text] [Related]
7. A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion. Salvador F; Deramoudt L; Leprêtre F; Figeac M; Guerrier T; Boucher J; Bas M; Journiac N; Peters A; Mars LT; Zéphir H Front Immunol; 2022; 13():755900. PubMed ID: 35185870 [TBL] [Abstract][Full Text] [Related]
9. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Kidd BA; Ho PP; Sharpe O; Zhao X; Tomooka BH; Kanter JL; Steinman L; Robinson WH Arthritis Res Ther; 2008; 10(5):R119. PubMed ID: 18826638 [TBL] [Abstract][Full Text] [Related]
10. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis. Stuerzebecher S; Martin R Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717 [TBL] [Abstract][Full Text] [Related]
11. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis. Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424 [TBL] [Abstract][Full Text] [Related]
13. Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents. Kesidou E; Touloumi O; Lagoudaki R; Nousiopoulou E; Theotokis P; Poulatsidou KN; Boziki M; Kofidou E; Delivanoglou N; Minti F; Hadjigeorgiou G; Grigoriadis N; Simeonidou C J Neuroinflammation; 2017 Nov; 14(1):227. PubMed ID: 29162133 [TBL] [Abstract][Full Text] [Related]
14. Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope. Pandey S; Dioni I; Lambardi D; Real-Fernandez F; Peroni E; Pacini G; Lolli F; Seraglia R; Papini AM; Rovero P Mol Cell Proteomics; 2013 Feb; 12(2):277-82. PubMed ID: 23139387 [TBL] [Abstract][Full Text] [Related]
15. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. Rostami A; Ciric B J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791 [TBL] [Abstract][Full Text] [Related]
16. CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells? Agahozo MC; Peferoen L; Baker D; Amor S Mult Scler Relat Disord; 2016 Sep; 9():110-7. PubMed ID: 27645355 [TBL] [Abstract][Full Text] [Related]
17. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats. Matsumoto Y; Park IK; Hiraki K; Ohtani S; Kohyama K Immunology; 2009 Sep; 128(1 Suppl):e250-61. PubMed ID: 19175799 [TBL] [Abstract][Full Text] [Related]
18. IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis. Lee LF; Axtell R; Tu GH; Logronio K; Dilley J; Yu J; Rickert M; Han B; Evering W; Walker MG; Shi J; de Jong BA; Killestein J; Polman CH; Steinman L; Lin JC Sci Transl Med; 2011 Jul; 3(93):93ra68. PubMed ID: 21795588 [TBL] [Abstract][Full Text] [Related]
19. Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody. Bing SJ; Ha D; Ahn G; Cho J; Kim A; Park SK; Yu HS; Jee Y Clin Exp Immunol; 2015 Jun; 180(3):419-31. PubMed ID: 25619397 [TBL] [Abstract][Full Text] [Related]
20. IFN-β treatment requires B cells for efficacy in neuroautoimmunity. Schubert RD; Hu Y; Kumar G; Szeto S; Abraham P; Winderl J; Guthridge JM; Pardo G; Dunn J; Steinman L; Axtell RC J Immunol; 2015 Mar; 194(5):2110-6. PubMed ID: 25646307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]